Use and early mortality outcomes of active surveillance in patients with intermediate‐risk prostate cancer
Author:
Affiliation:
1. Department of Radiation Oncology Dana‐Farber Cancer Institute, Brigham and Women's Hospital Boston Massachusetts
2. Division of Urology Brigham and Women’s Hospital Boston Massachusetts
Publisher
Wiley
Subject
Cancer Research,Oncology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.32202
Reference32 articles.
1. Cancer statistics, 2018
2. 20-Year Outcomes Following Conservative Management of Clinically Localized Prostate Cancer
3. 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer
4. Long-Term Follow-Up of a Large Active Surveillance Cohort of Patients With Prostate Cancer
5. Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prognostic Impact and Clinical Implications of Adverse Tumor Grade in Very Favorable Low- and Intermediate-Risk Prostate Cancer Patients Treated with Robot-Assisted Radical Prostatectomy: Experience of a Single Tertiary Referral Center;Cancers;2024-06-04
2. Effectiveness of auricular acupuncture and pelvic floor muscle training in the management of urinary incontinence following surgical treatment for prostate cancer: A randomized clinical trial;European Journal of Oncology Nursing;2024-02
3. The impact of prognostic group classification on prostate cancer progression in intermediate-risk patients according to the European Association of Urology system: results in 479 patients treated with robot-assisted radical prostatectomy at a single tertiary referral center;Therapeutic Advances in Urology;2024-01
4. A modeling study to estimate prostate cancer‐specific mortality on active surveillance for men with favorable intermediate‐risk prostate cancer: Results from the SEARCH cohort;Cancer Medicine;2023-04-09
5. Comparison of Outcomes of Active Surveillance in Intermediate-Risk Versus Low-Risk Localised Prostate Cancer Patients: A Systematic Review and Meta-Analysis;Journal of Clinical Medicine;2023-04-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3